Literature DB >> 17146583

In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains.

Christine Roques1, Sabine Brousse, Cédric Panizzutti.   

Abstract

The aim of this study was to determine the in vitro fungicidal and growth inhibitory activity of ciclopirox olamine alone (1% and 1.5%) or in association with 1% zinc pyrithione compared to 2% ketoconazole, against Malassezia species particularly involved in the pathogenesis of seborrheic dermatitis. Experiments were performed on Malassezia globosa IP 2387.96 and M. restricta IP 2392.96 strains. Growth inhibitory activity of the active compounds in solution was evaluated by measuring minimal inhibitory concentrations using a broth micro-method and their fungicidal activity by a filtration method after contact times between solutions and yeasts ranging from 3-5 to 30 min. Concerning the determination of minimal inhibitory concentration of ciclopirox olamine/zinc pyrithione, it revealed the marked synergistic inhibitory effect of the association, leading to a higher efficacy compared to ketoconazole. As to the fungicidal activity of ciclopirox olamine, it significantly increased with the contact time. After 15-30 min of contact between 1.5% ciclopirox olamine and Malassezia strains, a 2-log reduction of Malassezia counts was observed. The 1.5% ciclopirox olamine/1% zinc pyrithione association was characterized by a steady fungicidal efficacy whereas the 2% ketoconazole solution did not express any fungicidal effect. In conclusion, this study demonstrates the in vitro inhibitory and fungicidal efficacy of the ciclopirox olamine/zinc pyrithione association against Malassezia species and underscores its potential interest in the treatment of seborrheic dermatitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17146583     DOI: 10.1007/s11046-006-0075-0

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  32 in total

1.  Species identification and strain typing of Malassezia species stock strains and clinical isolates based on the DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions.

Authors:  Koichi Makimura; Yoshiko Tamura; Michinari Kudo; Katsuhisa Uchida; Hiuga Saito; Hideyo Yamaguchi
Journal:  J Med Microbiol       Date:  2000-01       Impact factor: 2.472

2.  [Mode of action of ciclopiroxolamine on Candida albicans].

Authors:  M Niewerth; M Schaller; H C Korting; B Hube
Journal:  Mycoses       Date:  2002       Impact factor: 4.377

3.  The prevalence of Malassezia yeasts in patients with atopic dermatitis, seborrhoeic dermatitis and healthy controls.

Authors:  Mari Helen Sandström Falk; Maria Tengvall Linder; Catharina Johansson; Jacek Bartosik; Ove Bäck; Tore Särnhult; Carl-Fredrik Wahlgren; Annika Scheynius; Jan Faergemann
Journal:  Acta Derm Venereol       Date:  2005       Impact factor: 4.437

4.  Treatment of seborrheic dermatitis.

Authors:  B A Johnson; J R Nunley
Journal:  Am Fam Physician       Date:  2000-05-01       Impact factor: 3.292

5.  Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo.

Authors:  R R Warner; J R Schwartz; Y Boissy; T L Dawson
Journal:  J Am Acad Dermatol       Date:  2001-12       Impact factor: 11.527

6.  Molecular analysis of Malassezia microflora on the skin of atopic dermatitis patients and healthy subjects.

Authors:  T Sugita; H Suto; T Unno; R Tsuboi; H Ogawa; T Shinoda; A Nishikawa
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

7.  Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial.

Authors:  Peter Altmeyer; Klaus Hoffmann
Journal:  Int J Dermatol       Date:  2004-07       Impact factor: 2.736

Review 8.  Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.

Authors:  S G Jue; G W Dawson; R N Brogden
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

Review 9.  Atopic dermatitis and fungi.

Authors:  Jan Faergemann
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 10.  The use of sulfur in dermatology.

Authors:  Aditya K Gupta; Karyn Nicol
Journal:  J Drugs Dermatol       Date:  2004 Jul-Aug       Impact factor: 2.114

View more
  6 in total

Review 1.  Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.

Authors:  Alessandro Subissi; Daniela Monti; Giuseppe Togni; Federico Mailland
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

Review 2.  Topical treatments for scalp psoriasis.

Authors:  Justin Gabriel Schlager; Stefanie Rosumeck; Ricardo Niklas Werner; Anja Jacobs; Jochen Schmitt; Christoph Schlager; Alexander Nast
Journal:  Cochrane Database Syst Rev       Date:  2016-02-26

3.  Clinical and biochemical assessment of maintenance treatment in chronic recurrent seborrheic dermatitis: randomized controlled study.

Authors:  Virginie Turlier; Cécile Viode; Elisabeth Durbise; Adeline Bacquey; Ophélie LeJeune; Rui Oliveira Soares; Christophe Lauze; Cécile Villeneuve; Amandine Rouquier; Christiane Casas; Daniel Redoules; Valérie Mengeaud; Anne-Marie Schmitt
Journal:  Dermatol Ther (Heidelb)       Date:  2014-03-19

4.  Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa.

Authors:  Andrew G S Warrilow; Claire L Price; Josie E Parker; Nicola J Rolley; Christopher J Smyrniotis; David D Hughes; Vera Thoss; W David Nes; Diane E Kelly; Theodore R Holman; Steven L Kelly
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

5.  Understanding the Mechanism of Action of the Anti-Dandruff Agent Zinc Pyrithione against Malassezia restricta.

Authors:  Minji Park; Yong-Joon Cho; Yang Won Lee; Won Hee Jung
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

6.  Newly Developed Anti-Dandruff Regimen, VB-3222, Delivers Enhanced Sensorial and Effective Therapeutic Benefits Against Moderate Adherent Dandruff.

Authors:  Suresh Sadhasivam; Kalpna Garkhal; Himanshi Singh; Vishal Yadav; Suresh Chawrai; Mukesh Ramnane; Shilpi Jain; Kabir Sardana; Shamik Ghosh
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.